Imaging: MRS/MRI/PET/SPECT: Summary

References

• Gredal O, Pakkenberg H, Karlsborg M, Pakkenberg B. Unchanged total number of neurons in motor cortex and neocortex in amyotrophic lateral sclerosis. J Neurosci Methods 2000; 95: 171–176.
   PubMed Web of Science ®Google Scholar
• Kew JJ, Goldstein LH, Leigh PN et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsycho- logical and positron emission tomography study. Brain 1993; 116: 1399–1423.
   Google Scholar
• Abrahams S, Goldstein LH, Kew JJ, Brooks DJ, Lloyd CM, Frith CD, Leigh PN. Frontal lobe dysfunction in amy- otrophic lateral sclerosis. A PET study. Brain 1996; 119: 2105–2120.
   Google Scholar
• Ellis CM, Suckling J, Amaro E Jr, Bullmore ET, Simmons A, Williams SC, Leigh PN. Volumetric analysis reveals corti- cospinal tract degeneration and extramotor involvement in ALS. Neurology 2001; 57(9): 1571–1578.
   PubMed Web of Science ®Google Scholar
• Ellis CM, Simmons A, Jones DK et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999; 53: 1051–1058.
   Google Scholar
• Brooks BR, Bushara K, Khan A, Hershberger J, Wheat JO, Belden D, Henningsen H. Functional magnetic resonance imaging (fMRI) clinical studies in ALS – paradigms, prob- lems and promises. ALS 2000; 2(Suppl 2): S23–S32.
   Google Scholar
• Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SC, Leigh PN. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 1998; 51: 1104–1109.
   PubMed Web of Science ®Google Scholar
• Ellis CM, Simmons A, Glover A, Dawson JM, Williams SC, Leigh PN. Quantitative proton magnetic resonance spec- troscopy of the subcortical white matter in motor neuron disease. ALS 2000; 1: 123–129.
   Google Scholar
• Chan S, Shungu DC, Douglas-Akinwande A, Lange DJ, Rowland LP. Motor neuron diseases: comparison of single voxel proton spectroscopy of the motor cortex with MR imaging of the brain. Radiology 1999; 212: 763–769.
   PubMed Web of Science ®Google Scholar
• Pohl C, Block W, Karitzky J et al. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amy- otrophic lateral sclerosis. Arch Neurol 2001; 58: 729–735.
   Google Scholar
• Pioro E. Proton magnetic resonance spectroscopy (1H-MRS) in ALS. ALS 2000; 1(Suppl 2): S7–S16.
   Google Scholar
• Bowen BC, Bradley WG. Amyotrophic lateral sclerosis. The search for a spectroscopic marker of upper motor neuron involvement. Arch Neurol 2001; 58: 714–716.
   Google Scholar
• Ciccarelli O, Wering DJ, Wheeler-Kingshott CA, Barker GJ, Parker GJ, Thompson AJ, Miller DH. Investigation of MS normal appearing white matter using diffusion tensor MRI with clinical correlations. Neurology 2001; 56: 926–933.
   PubMed Web of Science ®Google Scholar
• Eriksson SH, Rugg-Gunn FJ, Symms MR, Barker GJ, Duncan JS. Diffusion tensor imaging in patients with epilepsy and malformations of cortical development. Brain 2001; 124: 617–626.
   PubMed Web of Science ®Google Scholar
• Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001; 56: 304–311.
   PubMed Web of Science ®Google Scholar
• Barker GJ. Diffusion weighted imaging of the spinal cord and optic nerve. J Neurol Sci 2001; 186(Suppl 1): S45–S49.
   PubMedGoogle Scholar
• Kew JJ, Leigh PN, Playford ED, Passingham RE, Goldstein LH, Frackowiak RS, Brooks DJ. Cortical function in amy- otrophic lateral sclerosis. A positron emission tomography study. Brain 1993; 116: 655–680.
   Google Scholar
• Kew JJ, Brooks DJ, Passingham RE, Rothwell JC, Frackowiak RS, Leigh PN. Cortical function in progressive lower motor neuron disorders and amyotrophic lateral sclerosis: a com- parative PET study. Neurology 1994; 44: 1101–1110.
   PubMed Web of Science ®Google Scholar
• Ludolph AC, Langen KJ, Regard M et al. Frontal lobe dys- function in ALS: a neuropsychological and PET study. Acta Neurol Scand 1992; 85: 81–89.
   Google Scholar
• Turner MR, Leigh PN. Positron emission tomography (PET) – its potential to provide surrogate markers in ALS. ALS 2000; 1(Suppl 2): S17–S22.
   Google Scholar
• Azmitia EC, Gannon PJ, Kheck NM, Whitaker-Azmitia PM. Cellular localization of the 5HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 1996; 14: 35–46.
   PubMed Web of Science ®Google Scholar
• Brooks DJ, Doder M. Depression in Parkinson’s disease. Curr Opin Neurology 2001; 14: 465–470.
   PubMedGoogle Scholar
• Lloyd CM, Richardson MP, Brooks DJ, Al-Chalabi A, Leigh PN. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain 2000; 123: 2289–2296.
   PubMed Web of Science ®Google Scholar
• Hammers A, Koepp MJ, Richardson MP, Labbe C, Brooks DJ, Cunningham VJ, Duncan JS. Central benzodiazepine recep- tors in malformations of cortical development. A quantita- tive study. Brain 2001; 124: 1555–1565.
   Google Scholar
• Ferrer I, Tunon T, Serrano MT, Casas R, Alcantara S, Zujar MJ, Rivera RM. Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1993; 56: 257–261.
   PubMed Web of Science ®Google Scholar
• Mackawa S, Kibble M, Cotter D, Everall I, Leigh PN, Al-Sarraj S. Selective loss of inhibitory neurons in the cerebral cortex in motor neuron disease (abstract). ALS 2000; 2(Suppl 2): 139.
   Google Scholar
• Gagnin A, Myers R, Gunn RN et al. In vivo-visualisation of activated microglia by [11C](R)-PK11195-PET following herpes simplex encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 2001; 124: 2014–2027.
   Google Scholar